Why it's time to treat medicinal cannabis as an alternative therapy, not a pharmaceutical

The recent approval of two domestically produced cannabidiol (CBD) oil products—non-intoxicating cannabis compounds—may have provided new optimism to patients on cannabis prescriptions. Slow progress with product approvals had meant some patients had feared they would need to turn to the black market.

This post was originally published on this site